The prevalence of MPNST in patients without large deletions of the NF1 gene in our study (0%) was lower than that reported by Pasmant et al (3.1.%), however this bias might be caused by the small number of patients included[16]. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.